Zobrazeno 1 - 10
of 2 279
pro vyhledávání: '"Neoadjuvant chemoradiation"'
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background After receiving neoadjuvant chemoradiation, the number of examined lymph nodes in resectable gastroesophageal cancer (GEC) will decrease, this may not accurately determine the N staging. So our study evaluates the clinical signifi
Externí odkaz:
https://doaj.org/article/cee47976224f4996a6dfbdb2a65cf8b9
Publikováno v:
Journal of Medical Sciences, Vol 44, Iss 2, Pp 93-96 (2024)
This case report describes a successful treatment of rare double malignant fistulas in an advanced rectosigmoid junction tumor using neoadjuvant chemoradiation and surgery. An 81-year-old woman presented with poor appetite, abdominal fullness, dizzin
Externí odkaz:
https://doaj.org/article/ec2f579745dc44a1889dddb4c0bff62b
Publikováno v:
Annals of Coloproctology, Vol 39, Iss 6, Pp 447-456 (2023)
Purpose This systematic review and meta-analysis compared the outcomes of the watch-and-wait (WW) approach versus radical surgery (RS) in rectal cancers with clinical complete response (cCR) after neoadjuvant chemoradiotherapy. Methods This study fol
Externí odkaz:
https://doaj.org/article/93909bb0168d4e72a098c1168afb7889
Autor:
Yahang Liang, Hualin Liao, Haoran Shi, Tao Li, Yaxiong Liu, Yuli Yuan, Mingming Li, Aidi Li, Yang Liu, Yao Yao, Taiyuan Li
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe treatment strategy for stage II rectal mucinous adenocarcinoma (RMA) recommends neoadjuvant chemoradiotherapy (NCR) followed by total mesorectal excision (TME). However, the necessity of adjuvant chemotherapy (AC) remains controversial.
Externí odkaz:
https://doaj.org/article/cd9b511850ed4e1db43bc7bf86b756c4
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15664-15675 (2023)
Abstract Purpose To explore genomic biomarkers in rectal cancer by performing whole‐exome sequencing. Materials and Methods Pre‐chemoradiation (CRT) biopsy and post‐CRT surgical specimens were obtained from 27 patients undergoing neoadjuvant CR
Externí odkaz:
https://doaj.org/article/c2e46019e4e746538cbb68e7d9e39b71
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13309-13318 (2023)
Abstract Background and Objectives Neoadjuvant chemotherapy (nCT) appears in a few clinical studies as an alternative to neoadjuvant chemoradiation (nCRT) in selected patients with locally advanced rectal cancer (LARC). We aimed to compare the clinic
Externí odkaz:
https://doaj.org/article/fd9ec9dd3e1c4122bc59367120b7c90f
Autor:
Charles E. Gaber, Jyotirmoy Sarker, Abdullah I. Abdelaziz, Ebere Okpara, Todd A. Lee, Samuel J. Klempner, Ryan D. Nipp
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Background Neoadjuvant chemoradiation and chemotherapy are recommended for the treatment of nonmetastatic esophageal cancer. The benefit of neoadjuvant treatment is mostly limited to patients who exhibit pathologic complete response (pCR). E
Externí odkaz:
https://doaj.org/article/c5d19f1552254b888813b1817e9cb8ce
Autor:
Witold Rzyman, Małgorzata Łazar-Poniatowska, Robert Dziedzic, Tomasz Marjański, Mariusz Łapiński, Rafał Dziadziuszko
Publikováno v:
Current Oncology, Vol 30, Iss 5, Pp 4551-4562 (2023)
Objectives: Treatment of superior sulcus tumors (SST) using concurrent chemoradiation followed by surgery is a current standard. However, due to the rarity of this entity, clinical experience in its treatment remains scarce. Here, we present the resu
Externí odkaz:
https://doaj.org/article/10fa31ad8ba44a279d2749fcc6d78148
Autor:
Catarina Macedo‐Silva, Vera Constâncio, Vera Miranda‐Gonçalves, Pedro Leite‐Silva, Sofia Salta, João Lobo, Rita Guimarães, Carina Carvalho‐Maia, Davide Gigliano, Mónica Farinha, Olga Sousa, Rui Henrique, Carmen Jerónimo
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8777-8788 (2023)
Abstract Background Esophageal cancer (ECa) is associated with high mortality, mostly due to late diagnosis, precluding curativeintent surgery. Hence, neoadjuvant chemoradiation (ChRT) is recommended in most patients regardless of histological subtyp
Externí odkaz:
https://doaj.org/article/d970b954e26b4a219791784a6f9bb2cf
Autor:
Tadataka Takagi, Minako Nagai, Satoshi Nishiwada, Taichi Terai, Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, Yuichiro Kohara, Masayuki Sho
Publikováno v:
Annals of Gastroenterological Surgery, Vol 7, Iss 2, Pp 326-335 (2023)
Abstract Aim There is an urgent need to establish biomarkers for the treatment of pancreatic ductal adenocarcinoma (PDAC). The aim of this study was to investigate the usefulness of the combined assessment of carbohydrate antigen 19‐9 (CA19‐9), c
Externí odkaz:
https://doaj.org/article/82646a51d8674b5b8343ef6c2f82c6f4